Navegando por Palavras-chave "medication"

Agora exibindo 1 - 3 de 3
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    International prescribing practices in obsessive-compulsive disorder (OCD)
    (Wiley-Blackwell, 2016) Brakoulias, Vlasios; Starcevic, Vladan; Belloch, Amparo; Dell'Osso, Liliana; Ferrao, Ygor A.; Fontenelle, Leonardo F.; Lochner, Christine; Marazziti, Donatella; Martin, Andrew; Matsunaga, Hisato; Miguel, Euripedes C.; Reddy, Y. C. Janardhan; do Rosario, Maria C. [UNIFESP]; Shavitt, Roseli G.; Sundar, Arumugham Shyam; Stein, Dan Joseph; Viswasam, Kirupamani
    ObjectivesTo assess rates of psychotropic medication use in patients with obsessive-compulsive disorder (OCD) in seven different countries on five continents and to compare these with international treatment guidelines. MethodsResearchers in the field of OCD were invited to contribute summary statistics on the characteristics of their patients with OCD and on their incidence of psychotropic use. Consistency of summary statistics across countries was evaluated. ResultsThe data came from Brazil (n=955), Italy (n=750), South Africa (n=555), Japan (n=382), Australia (n=213), India (n=202) and Spain (n=82). The majority (77.9%
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Prevenção da aterosclerose e tratamento medicamentoso de anormalidades lipídicas de alto risco em crianças e adolescentes
    (Sociedade Brasileira de Pediatria, 2009-02-01) Castro, Priscilla Severino Gonçalves De [UNIFESP]; Oliveira, Fernanda Luisa Ceragioli [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)
    OBJECTIVE: To discuss risk factors of atherosclerosis in pediatrics, dietary and physical activity guidelines, and, mainly, drug treatment of high-risk lipid abnormalities. SOURCES: Data were obtained from articles indexed in MEDLINE, published over the last 5 years. SUMMARY OF THE FINDINGS: Children with severe dyslipidemia or additional risk factors such as family history of early cardiovascular disease or other signs of metabolic syndrome may need treatment with hypolipidemic drugs. New recommendations from the U.S. guidelines indicate drug treatment before the age of 10 years according to the magnitude of the additional risk factors for cardiovascular disease. Pediatricians should know when to diagnose dyslipidemia, when to indicate drug treatment and which medication can be used in children and adolescents with the least risk or harm to their development. CONCLUSIONS: The first-line treatment of dyslipidemia consists of lifestyle changes, focusing on prevention. Children with high-risk lipid abnormalities should be considered for drug treatment. Decisions to be made together with the parents must be evaluated taking into consideration risks and benefits of the medication to the patient.
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    A terapia cognitivo-comportamental em grupo no tratamento de transtorno de déficit de atenção/hiperatividade (TDAH)
    (Universidade Federal de São Paulo (UNIFESP), 2016-08-31) Scaramuzza, Luzia Flavia Coelho [UNIFESP]; Miranda, Monica Carolina [UNIFESP]; Universidade Federal de São Paulo (UNIFESP)
    Cognitive-behavioral therapy (CBT) is one of the most extensively researched non-medicaments methods of treating patients with attention deficit hyperactivity disorder (ADHD). Latin America is short of scientifically sound CBT protocols to treat children and adolescents, although sorely needed for the public health service. The present study developed a group-CBT protocol to evaluate their effects in cognitive and behavioral domains and social skills. The group-CBT protocol developed consisted of 20 sessions based on six aspects: psychoeducation; parental training; organization and planning; problem solving; emotional regulation, and social skills. For the study reported in Article 1, the sample of 60 was divided in two groups of 30 children each, unimodal- medication (M10.08 ± 2.17) and multimodal - medication and CBT (M10.2 ± 1.86). All children were administered long-term methylphenidate 20 mg. Pre- and post-treatment tests covered sustained attention, working memory, social skills, behavioral scales and executive function questionnaire. There was no difference between treatment groups on cognitive and behavioral measurements. The multimodal group showed more improvement on social skills as seen in frequency indicators for empathy, assertiveness and self-control subscales and difficulty indicators for assertiveness and self-control subscales. Article 2 assessed use of the token technique over a 10-week treatment period. The behavior of the 25 multimodal group children (M10.11±1.79) was logged and problem behavior evaluated in 11 categories: inattention, impulsivity, hyperactivity, disorganization, disobeying rules or routines, poor self-care, verbal / physical aggression, intolerance of disappointment, compulsive behavior, anti-social behavior, lack of initiative. Over the 10 week period, there was a significant decline in seven categories: impulsivity, hyperactivity, disorganization, disobeying rules and routines, poor self-care, intolerance of disappointment, and antisocial behavior. The results showed that the group-CBT protocol may be used for children and adolescents with ADHD. Although evidence for effect of different treatments on cognitive measures and behavioral scales was lacking, the significant improvement found in day to day behavior showed that functional assessments are relevant for this type of study.